Peter Bartenstein
Overview
Explore the profile of Peter Bartenstein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
540
Citations
11060
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dinkel L, Hummel S, Zenatti V, Malara M, Tillmann Y, Colombo A, et al.
Sci Transl Med
. 2024 Dec;
16(776):eadl4616.
PMID: 39630885
Niemann-Pick type C (NPC) disease is an inherited lysosomal storage disorder mainly driven by mutations in the gene, causing lipid accumulation within late endosomes/lysosomes and resulting in progressive neurodegeneration. Although...
2.
Rubinstein G, Ilhan H, Bartenstein P, Lehner S, Hacker M, Todica A, et al.
Diagnostics (Basel)
. 2024 Nov;
14(22).
PMID: 39594152
Atherosclerosis and its sequels, such as coronary artery disease and cerebrovascular stroke, still represent global health burdens. The pathogenesis of atherosclerosis consists of growing calcified plaques in the arterial wall...
3.
Shojaei M, Schaefer R, Schlepckow K, Kunze L, Struebing F, Brunner B, et al.
Theranostics
. 2024 Oct;
14(16):6319-6336.
PMID: 39431020
Triggering receptor expressed on myeloid cells 2 (TREM2) plays an essential role in microglia activation and is being investigated as a potential therapeutic target for modulation of microglia in several...
4.
Lindheimer F, Lindner M, Oos R, Honarpisheh M, Zhang Y, Lei Y, et al.
Front Nucl Med
. 2024 Oct;
3:1157480.
PMID: 39355020
Introduction: Islet xenotransplantation may be a therapeutic option in type 1 diabetes. Recent advances in generating genetically modified source pigs offer advantages as immune suppressants can potentially be eliminated after...
5.
Kunte S, Unterrainer L, Kunz W, Winkelmann M, Lindner S, Jurkschat K, et al.
Clin Nucl Med
. 2024 Oct;
49(12):e689-e690.
PMID: 39354685
A 64-year-old woman with meningioma presented with left-sided lenticulostriatal ischemia following craniotomy and debulking of a sphenoid wing meningioma. For subsequent radiotherapy planning, an SSTR-targeted PET/CT using the novel ligand...
6.
Bartos L, Kunte S, Wagner S, Beumers P, Schaefer R, Zatcepin A, et al.
Neuroimage
. 2024 Sep;
300:120860.
PMID: 39332748
Purpose: 2-Fluorodeoxyglucose-PET (FDG-PET) is a powerful tool to study glucose metabolism in mammalian brains, but cellular sources of glucose uptake and metabolic connectivity during aging are not yet understood. Methods:...
7.
Janbain A, Farolfi A, Guenegou-Arnoux A, Romengas L, Scharl S, Fanti S, et al.
JMIR Cancer
. 2024 Sep;
10:e60323.
PMID: 39303279
Background: Salvage radiation therapy (sRT) is often the sole curative option in patients with biochemical recurrence after radical prostatectomy. After sRT, we developed and validated a nomogram to predict freedom...
8.
Dilcher R, Wall S, Gross M, Katzdobler S, Wagemann O, Palleis C, et al.
Alzheimers Dement
. 2024 Sep;
20(10):6896-6909.
PMID: 39263969
Introduction: Recent advances in biomarker research have improved the diagnosis and monitoring of Alzheimer's disease (AD), but in vivo biomarker-based workflows to assess 4R-tauopathy (4RT) patients are currently missing. We...
9.
Zatcepin A, Gnorich J, Rauchmann B, Bartos L, Wagner S, Franzmeier N, et al.
Mol Neurodegener
. 2024 Sep;
19(1):64.
PMID: 39238030
Background: Microglial activation is one hallmark of Alzheimer disease (AD) neuropathology but the impact of the regional interplay of microglia cells in the brain is poorly understood. We hypothesized that...
10.
Parhizkar S, Arzberger T, Brendel M, Kleinberger G, Deussing M, Focke C, et al.
Nat Neurosci
. 2024 Aug;
27(9):1858-1859.
PMID: 39143410
No abstract available.